 | Up a level |
Journal Article
Hoeper, Marius M., McLaughlin, Vallerie V., Albert Barbera, Joan, Frost, Adaani E., Ghofrani, Hossein-Ardeschir, Peacock, Andrew J., Simonneau, Gerald, Rosenkranz, Stephan, Oudiz, Ronald J., White, R. James, Miller, Karen L., Langley, Jonathan, Harris, Julia H. N., Blair, Christiana, Rubin, Lewis J. and Vachiery, Jean-Luc (2016). Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study. Lancet Resp. Med., 4 (11). S. 894 - 902. OXFORD: ELSEVIER SCI LTD. ISSN 2213-2600
McLaughlin, Vallerie V., Vachiery, Jean-Luc, Oudiz, Ronald J., Rosenkranz, Stephan, Galie, Nazzareno, Barbera, Joan A., Frost, Adaani E., Ghofrani, Hossein-Ardeschir, Peacock, Andrew J., Simonneau, Gerald, Rubin, Lewis J., Blair, Christiana, Langley, Jonathan and Hoeper, Marius M. (2019). Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial. J. Heart Lung Transplant., 38 (12). S. 1286 - 1296. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1557-3117
White, R. James, Vonk-Noordegraaf, Anton, Rosenkranz, Stephan, Oudiz, Ronald J., McLaughlin, Vallerie V., Hoeper, Marius M., Gruenig, Ekkehard, Ghofrani, Hossein-Ardeschir, Chakinala, Murali M., Barbera, Joan A., Blair, Christiana, Langley, Jonathan and Frost, Adaani E. (2019). Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension. Respir. Res., 20 (1). LONDON: BMC. ISSN 1465-993X